213 related articles for article (PubMed ID: 35222371)
1. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma.
Chen Y; Jiang Y; Li X; Huang H; Zhou Y; Zhang C; Wang S; Bohnenberger H; Gao Y
Transl Lung Cancer Res; 2024 May; 13(5):1084-1100. PubMed ID: 38854940
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
Cao X; Ji Y; Li J; Liu Z; Chen C
Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response.
Gao M; Wang M; Chen Y; Wu J; Zhou S; He W; Shu Y; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):171. PubMed ID: 38558328
[TBL] [Abstract][Full Text] [Related]
6. Identification of a methyltransferase-related long noncoding RNA signature as a novel prognosis biomarker for lung adenocarcinoma.
Sun YY; Li S; Liu C; Pan Y; Xiao Y
Aging (Albany NY); 2024 May; 16(10):8747-8771. PubMed ID: 38771129
[TBL] [Abstract][Full Text] [Related]
7. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma.
Zhang J; Li Y; Yang Y; Huang J; Sun Y; Zhang X; Kong X
Cancer Sci; 2024 Jan; 115(1):109-124. PubMed ID: 38015097
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344
[TBL] [Abstract][Full Text] [Related]
9. A Novel Gene Signature Based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients.
Ma C
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38529604
[TBL] [Abstract][Full Text] [Related]
10. A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma.
Xu J; Yu M; Fan W; Feng J
Transl Cancer Res; 2024 Feb; 13(2):525-541. PubMed ID: 38482436
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and immunotherapeutic implications of bilirubin metabolism-associated genes in lung adenocarcinoma.
Ren K; Ling X; Chen L; Li Z; Huang T
J Cell Mol Med; 2024 May; 28(9):e18346. PubMed ID: 38693853
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma.
Guo Z; Zhang X; Yang D; Hu Z; Wu J; Zhou W; Wu S; Zhang W
Sci Rep; 2024 May; 14(1):10348. PubMed ID: 38710798
[TBL] [Abstract][Full Text] [Related]
13. Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing.
Huang L; Lou N; Xie T; Tang L; Han X; Shi Y
Cancer Immunol Immunother; 2023 Oct; 72(10):3259-3277. PubMed ID: 37458771
[TBL] [Abstract][Full Text] [Related]
14. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
[TBL] [Abstract][Full Text] [Related]
15. A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.
Carr SR; Wang H; Hudlikar R; Lu X; Zhang MR; Hoang CD; Yan F; Schrump DS
J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1554-1564. PubMed ID: 37608989
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
Zhang H; Cao C; Xiong H
Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
[TBL] [Abstract][Full Text] [Related]
17. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in lung adenocarcinoma.
Liu Y; Hu S; Teng M; Qing Y; Dong X; Chen L; Ai K
J Gene Med; 2024 Feb; 26(1):e3610. PubMed ID: 37985130
[TBL] [Abstract][Full Text] [Related]
18. Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma.
Luo J; An J; Jia R; Liu C; Zhang Y
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38500277
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
[TBL] [Abstract][Full Text] [Related]
20. Machine-learning developed an iron, copper, and sulfur-metabolism associated signature predicts lung adenocarcinoma prognosis and therapy response.
Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
Respir Res; 2024 May; 25(1):206. PubMed ID: 38745285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]